Recently, the efficacy of an anti-IL-36R antibody in AD was demonstrated in a clinical trial [22] and IL-36 cytokine family involvement in AD pathogenesis is receiving a lot of attention. This evidence concerns the gene IL1RL2 and Alzheimer disease.